Company intelligence / Profile preview

AB&B BIO-TECH-B

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

AB&B Bio-Tech is a biotechnology company specializing in the development and manufacturing of high-quality raw materials for in vitro diagnostics (IVD). The company focuses on producing monoclonal antibodies, polyclonal antibodies, and recombinant proteins used in various diagnostic assays, including chemiluminescence, immunoturbidimetry, and lateral flow tests. Their product portfolio covers critical clinical areas such as inflammation markers, cardiac biomarkers, and infectious diseases. AB&B Bio-Tech serves global diagnostic kit manufacturers by providing essential biological components for accurate clinical testing.

Therapeutic areas: Infectious DiseasesCardiovascularImmunology
Modalities: AntibodyBiologicRecombinant protein
Industry: Chemicals & Materials

Beyond the preview

Go deeper on AB&B BIO-TECH-B.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AB&B BIO-TECH-B.

Explore the full profile